General
| Peptide: | LL-37 |
| Microorganism: | Staphylococcus epidermidis ATCC 35984 |
| Administration: | |
| Stage: | Adhesion (1-2h) |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Crystal violet assay | 21 - 50% | 0.223 uM | |
| Crystal violet assay | 21 - 50% | 0.891 uM | |
| Crystal violet assay | 51 - 90% | 1.782 uM | |
| Crystal violet assay | 51 - 90% | 3.563 uM | |
| Crystal violet assay | 51 - 90% | 7.126 uM |
Reference
- Ã. Hell, C.G. Giske, A. Nelson, U. Römling, G. Marchini Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation ofStaphylococcus epidermidis
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com